• A study to compare the effectiveness of rituximab and a placebo in patients with interstitial lung disease associated with rheumatoid arthritis

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • A study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Greece Hungary Italy Poland Spain

  • An observational study of carbidopa and levodopa use with a new dispensing device and app in patients with Parkinson’s disease

    Recruiting

    3 1 1 1
    Investigated drugs:
    Sweden

  • Study of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • A study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • A study comparing the effectiveness of a simeticone drug combination and a sodium picosulfate drug combination for bowel preparation in patients undergoing colorectal cancer screening.

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of the effect of hyperbaric oxygen therapy on the bacteria in chronic wounds

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria

  • A study to evaluate the effectiveness and safety of iadademstat in adults with essential thrombocythemia who do not respond well to or cannot tolerate hydroxyurea

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

    Recruiting

    2 1 1 1
    Investigated drugs:
    Sweden

  • A study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease

    Recruiting

    3 1
    Investigated diseases:
    France The Netherlands Poland Slovakia

powered by